Creative Biolabs owns advanced platforms to discover virology antibodies to meet customers' objectives.
Over the last 10 years, Creative Biolabs has becoming a leader of recombinant antibody (rAb) discovery, engineering and manufacturing, providing high quality service to customers in academia andindustry fields all over the world. Now we focus on antibody discovery services for virology researches. Empowered by advanced phage and yeast display platform, hybridoma platform, B cell sorting platform and single B cell sequencing technology, we are dedicated to providing specific virology antibodies within agreed timelines.
Virus is a kind of infectious agent that replicates only inside the living cells of an organism. Viruses infect all types of life forms, from animals, plants to microorganisms, including bacteria and archaea. To date, there are more than 5000 virus species have been described in detail. Examples of common human diseases caused by viruses include the common cold, influenza, chickenpox, and cold sores. Many serious diseases such as rabies, Ebola virus disease, Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS), avian influenza, and Severe Acute Respiratory Syndrome (SARS) are caused by viruses. Therefore, exploring novel virology antibodies is essential to meet increasing researches needs.
ViroAntibody refers to the antibody, especially for virology researches. With scientific expertise and advanced platforms, Creative Biolabs is committed to delivering high quality antibodies for better outcomes. In terms of ViroAntibody discovery, we pay more attention to:
In addition, we also provide personalized antibody discovery services for other viruses. If you have any requirements, please reach out to our scientists for assistance.
Creative Biolabs utilizes a unique combination of in vitro and in vivo technologies, driven by rigorous computational analyses, as sources for the viroantibody discovery. We employ a variety of antibody libraries to identify distinctive antibody sequences against our clients‘ targets. We provide a seamless and sophisticated transition between library selection, hybridoma and B cell antibody sequencing strategies. Moreover, we provide a wide range of options for the de novo discovery of antibodies against virtually all targets in scFv, Fab, IgG or bi-specific formats.
Our final goal is our client's 100% satisfaction. Our highly trained staff will strictly implement quality control procedures for antibody production. We adhere to the transparency of all quality data in every stage for top standard in quality virology research reagents.
Creative Biolabs' ViroAntibody discovery services are tailored for each project to meet or exceed the specific objectives. Our scientific expertise and technology platforms have been refined and advanced over the years, delivering a highly specific antibody for better outcomes. For flexibility, we can provide end-to-end services or a single service at any stage of the antibody discovery process. Would you be interested in any details in ViroAntibody discovery services, or ViroAntibody engineering services, or any customized ViroAntibody services, please feel free to contact us.